0.02
—
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Epsilon Healthcare
Its shares trade on ASX under the ticker EPN.AX. It has been listed since 4 May 2017. In the fiscal year to 31 December 2025, it reported revenue of A$9.4m and a net loss of A$1.3m. At that date it held total assets of A$17.9m and shareholders' equity of A$1.9m.
Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-05-04. The Company’s segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The firm owns a medicinal cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and Medimar Platform, which is an end-to-end e-commerce solution for nutraceuticals and cannabis. In addition, the Company operates a cannabis cultivation solutions provider based in Vancouver, Canada. The firm also provides advisory services related to medicinal cannabis. Its subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 4 May 2017
- Website
- epsilonhealthcare.com.au ↗
Leadership
Pay as last reported
- Mr. Alan BeasleyNon-Executive Chairman of the BoardA$55,000
- Mr. Peter GiannopoulosGroup Chief Executive Officer, Managing Director, Executive Director, since 2023
- Ms. Lin LiGroup Financial Controller
- Mr. Jason ColquhounKey Management Personnel
- Ms. Laura HarveyKey Management PersonnelA$232,685
- Ms. Diandra PhippsKey Management PersonnelA$90,525
- Mr. Daniel KaplonCompany Secretary
- Mr. Richard LeggeCompany Secretary
- Mr. Marcelo MoraCompany Secretary
- Ms. Zoe HutchingsNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Epsilon Healthcare Ltd. owns a medicinal cannabis manufacturing facility in the Southern Hemisphere.
- The company operates Tetra Health clinic and Medimar Platform for e-commerce solutions.
- Epsilon Healthcare has subsidiaries like Dragon Vision Limited and Canndeo Pty Ltd.
Weaknesses
- The company's hydroponics equipment business is limited to the Southern Hemisphere.
- Epsilon Healthcare's cannabis cultivation solutions provider is based in Vancouver, Canada.
- The firm's advisory services related to medicinal cannabis are not specified in detail.
Opportunities
- Epsilon Healthcare can expand its medicinal cannabis delivery in the Southern Hemisphere.
- The company can leverage Tetra Health clinic for broader medical cannabis services.
- Epsilon Healthcare may grow through its subsidiaries like THC Pharma Pty Ltd.
Threats
- Epsilon Healthcare faces regulatory challenges in the pharmaceutical industry.
- The company's reliance on the Southern Hemisphere for manufacturing poses risks.
- Epsilon Healthcare's cannabis cultivation solutions provider in Vancouver may face geopolitical issues.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.